Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Stuart McGuire and Jim Szymeczek

CRO fills two senior roles

Chiltern Stuart McGuireContract research organisation (CRO) Chiltern has promoted Stuart McGuire and Jim Szmeczek to senior roles.

McGuire (pictured right) is based in Slough, UK and becomes vice president, global business development and will also join the firm's group executive board.

He has been with the company for more than 12 years and during that time he led Chiltern's global business development team, a function the firm said has seen significant growth.

Chiltern has also promoted Jim Szymeczek, who becomes vice president, global information technology and systems.

Szymeczek, who is based in Wilmington, US, has more than 22 years of data and analytical science experience and joined Chiltern in 2006.

In his new role, he will oversee and provide strategy for the global IT team in its three structural areas: IT operations, clinical systems and commercial systems. 

Szymeczek will also be involved with technology related partnerships and sponsor activities.

Jim Esinhart, Chiltern's CEO, said of McGuire and Szmeczek: “Their leadership and depth of experience strengthens Chiltern's mission of delivering high quality, innovative and responsive services to meet our clients' needs.”

27th March 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics